This Viewpoint discusses shifts in social norms toward acceptance of obesity as normal and proposes harnessing the same peer effects that have destigmatized obesity to promote and spread healthy behaviors.
This Viewpoint discusses the prospects for treatment of obesity through identification of genetic, metabolic, behavioral, and environmental risk factors and an understanding of factors that account for variability in the success of treatment.
This Viewpoint discusses approaches that clinicians can take when advising overweight or obese patients to achieve weight control via calorie reduction.
This Viewpoint uses the 2017 Ninth Circuit ruling enjoining San Francisco from requiring a health warning statement on sugar-sweetened beverages to discuss modifications that would make the warnings legally justifiable.
This Viewpoint discusses the merits and challenges to implementing taxes on sugar-sweetened beverages aimed at reducing their consumption in an effort to curb US obesity rates.
This Viewpoint reviews evidence comparing the relative importance of cardiorespiratory fitness and obesity with all-cause and cardiovascular disease–related mortality, and calls for accurate measures of physical activity and fitness in future studies investigating associations between obesity and mortality.
In this essay, Jerry Avorn considers physicians’ social responsibility to initiate discussions with their patients about changes in health policy proposed by politicians that will affect patients' quality and continuity of care.
This study reports 5-year weight loss outcomes for participants in the SLEEVEPASS equivalence trial with morbid obesity managed with laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass.
This randomized clinical trial compares the effects of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on 5-year excess weight loss in patients with morbid obesity.
This report describes 5-year blood pressure, Hemoglobin A1c, and lipid levels among participants previously randomized to Roux-en-Y gastric bypass surgery vs no surgery for management of obesity and type 2 diabetes.
This cohort study uses Israeli electronic health record data to compare mortality of obese adult patients who underwent bariatric surgery (laparoscopic banding, Roux-en-Y gastric bypass, or laparoscopic sleeve gastrectomy) vs obese adults receiving nonsurgical usual care management.
This cohort study uses Norwegian registry data to compare long-term changes in hypertension, diabetes, depression, and opioid use among patients with severe obesity treated with bariatric surgery or specialized medical treatment.
This commentary discusses a study published in JAMA Surgery reporting 7-year weight and health outcomes for patients in the Longitudinal Assessment of Bariatric Surgery (LABS) Study who underwent Roux-en-Y gastric bypass or laparoscopic adjustable gastric banding.
This study estimates how much the 1.5¢-per-ounce tax on sugar-sweetened beverages in Philadelphia raised retail prices of soft drinks at the Philadelphia International Airport 1 month after implementation.
This Medical News article discusses clinical use of a very-low-carb, high-fat diet for weight loss and type 2 diabetes treatment.
This JAMA Patient Page describes the sleeve gastrectomy procedure as a weight loss treatment for obese persons.